Table III.
Clinical Characteristics of Patients With Human Coronavirus (HCoV) Infections
| Parameters | HCoV (%) | |||
|---|---|---|---|---|
| OC43 | 229E | HKU1 | NL63 | |
| No. of patients | 50 | 15 | 14 | 8 |
| Age range (year) | 14–90 | 14–68 | 24–78 | 15–85 |
| Age mean/median (year) | 47.3/46 | 37.9/36 | 41.2/27.5 | 34.6/18.5 |
| Gender (M/F) | 16/34 | 6/9 | 7/7 | 6/2 |
| URTI | 45 (90.0)a | 15 (100) | 12 (85.7) | 7 (87.5) |
| LRTI | 5 (10.0) | 0 | 2 (14.3) | 1 (12.5) |
| Clinical symptoms | ||||
| Cough | 26 (52.0) | 7 (46.7) | 6 (42.9) | 4 (50.0) |
| Sputum production | 6 (12.0) | 3 (20.0) | 0 | 2 (25.0) |
| Headache | 34 (68.0) | 11 (73.3) | 9 (64.3) | 6 (75.0) |
| Muscle pain | 29 (58.0) | 12 (80.0) | 12 (85.7) | 6 (75.0) |
| Sore throat | 33 (66.0) | 12 (80.0) | 8 (57.1) | 6 (75.0) |
| Chilly | 37 (74.0) | 12 (80.0) | 11 (78.6) | 6 (75.0) |
| Vomiting | 1 (2.0) | 12 (80.0) | 0 | 0 |
| Runing nose | 36 (72.0) | 12 (80.0) | 9 (64.3) | 5 (62.5) |
| Sneezing | 30 (60.0) | 12 (80.0) | 8 (57.1) | 4 (50.0) |
| Peripheral blood tests | ||||
| Mean leukocyte count (×109/L) | 7.5 ± 1.6 | 6.5 ± 1.8b | 8.1 ± 1.7 | 8.1 ± 1.8 |
| Co‐detection | 5 (10.0) | 4 (26.7) | 2 (14.3) | 0 |
| EV (n = 2) | HRV (n = 2) | HRV (n = 1) | ||
| PIV3 (n = 2) | IFVA (n = 1) | PIV3 (n = 1) | ||
| EV + HRV (n = 1) | IFVB (n = 1) | |||
LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection.; PIV, parainfluenza virus; EV, enterovirus; IFV, influenza virus; HRV, human rhinovirus.
a
The numbers in parentheses indicate the percentages of positive infection in total samples.
b
Student's t‐test: P = 0.013.